PR
Praxis Precision
PRAX·NASDAQCambridge MAFounded 2015120 employees
Mid CapbiotechPublicNeurology
Platform: Ion Channel
Market Cap
$3B
All Drugs
3
Clinical Trials
7
Failed / Terminated
1
FDA Approved
1
Stock Price & Catalysts (PRAX)
Loading PRAX stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Cevinaritide | PRA-4072 | Phase 3 | 4 | AuroraA | DLBCLCSU | ||
| PRA-419 | PRA-419 | Approved | 1 | Cl18.2 | ETHeart Failure | ||
| Talatenlimab | PRA-9026 | Phase 1/2 | 2 | KIF18A | MCC |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (5)